Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of the Levonorgestrel Intrauterine Device (Mirena) to Treat Complex Atypical Hyperplasia and Grade 1 Endometrioid Endometrial Carcinoma

NCT00788671 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00788671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00788671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of the Levonorgestrel Intrauterine Device (Mirena) to Treat Complex Atypical Hyperplasia and Grade 1 Endometrioid Endometrial Carcinoma
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 3, 2008
Completion date
November 30, 2027
Enrollment
69 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

atypical endometrial hyperplasia, stage i uterine corpus cancer ajcc v7, stage ia uterine corpus cancer ajcc v7, stage ib uterine corpus cancer ajcc v7, stage ii uterine corpus cancer ajcc v7